Back to Agenda
Prescription Drug Marketing Regulatory Primer
Session Chair(s)
Lucy Rose, MBA
President
Lucy Rose and Associates, United States
This interactive workshop will provide a basic introduction to the regulation of prescription drug advertising and promotion. The speakers will cover such important information as fair balance, required claim support, comparative claims, preapproval activities and medical conventions.
**Due to workshop format, seating will be limited and will be available on a first come, first served basis.
The Boston Convention and Exhibition Center (BCEC) has stringent regulations on maximum room capacities, and they are strictly enforced. Once all seats are occupied, DIA will be required to close the workshop, and no more participants will be admitted. Interested attendees are encouraged to arrive at workshops early in order to ensure seating. Please note, as a workshop with interactivity, this event will not be recorded.
Learning Objective : Discuss important environmental forces and agencies impacting the regulation of prescription drug promotion; Apply advertising and promotional regulations to advertising/marketing materials; Explain the importance of reviewing FDA regulatory letters as they apply to these regulatory decisions.
Speaker(s)
FDA Point of View
Thomas W. Abrams, MBA, RPh
Former FDA, United States
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
Have an account?